Glycobiology Advance Access published online on November 26, 2002
Glycobiology, doi:10.1093/glycob/cwg020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2002 Oxford University Press
ORIGINAL ARTICLES
1 Laboratoires SERONO SA, Serono Biotech Center, Zone Industrielle B, CH-1809 Fenil-Sur-Corsier, Switzerland The glycan moiety of human recombinant gonadotrophins (r-hFSH, r-hLH and r-hCG) produced in Chinese Hamster Ovary (CHO) cell lines has been characterised by a combination of chromatographic and mass spectrometric techniques including both Matrix-Assisted Laser Desorption Ionisation (MALDI) and electrospray (ES). Two glycan mapping methods have been developed for the three gonadotrophins that allow the separation of the glycans according to either their charge or sialylation level, or according to their antennarity. A method was also developed for r-hCG that permits the complete resolution of the N-glycan from the O-glycan species. Whereas the structure found for the N-glycans of the gonadotrophins was in agreement with the complex type model, the structure for an O-glycan of r-hCG, not yet described, has been unambiguously determined using nanoES Ion Trap mass spectrometry. Using these two glycan mapping methods, the high level of batch-to-batch consistency achieved for the glycosylation of the three recombinant gonadotrophins in commercial production has been shown. These data demonstrate the tight control that can be achieved in the manufacturing of complex recombinant therapeutic glycoproteins, which is a prerequisite to the delivering of a guaranteed dose of drug from vial to vial, and in turn to ensure the clinical efficacy of the product.
Revised on September 20, 2002
Accepted on September 23, 2002
Glycosylation of human recombinant gonadotrophins: characterisation and batch-to-batch consistency
2 Laboratoire de Spectrométrie de Masse Bio-Organique, ECPM, UMR CNRS 7509, Université Louis Pasteur, 25 rue Becquerel, 67087 Strasbourg cedex, France
Key words: batch-to-batch consistency / glycoprotein / mass spectrometry / N-glycan structure / O-glycan structure
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
U.-H. Stenman Detection of Illicit Use of Growth Hormone Clin. Chem., March 1, 2009; 55(3): 387 - 388. [Full Text] [PDF] |
||||
![]() |
A. Balen, P. Platteau, A. N. Andersen, P. Devroey, L. Helmgaard, J.-C. Arce, and for the Bravelle Ovulation Induction (BOI) Study G Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial Hum. Reprod., July 1, 2007; 22(7): 1816 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Valmu, H. Alfthan, K. Hotakainen, S. Birken, and U.-H. Stenman Site-specific glycan analysis of human chorionic gonadotropin {beta}-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry Glycobiology, December 1, 2006; 16(12): 1207 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF] |
||||



